In addition to prevalent clinicopathological factors, serum positivity for carcinoembryonic antigen (CEA) mRNA has been proposed as a surrogate marker for circulating tumor cells (CTCs) [9–12], and the presence of CTCs in peripheral blood at ≥ 24 h after surgery has been reported to be an independent risk factor [13]. Here, CEACAM5 is linked to neoplasm.